Logo image of CFLT

CONFLUENT INC-CLASS A (CFLT) Stock Fundamental Analysis

NASDAQ:CFLT - Nasdaq - US20717M1036 - Common Stock - Currency: USD

21.84  -0.05 (-0.23%)

After market: 21.96 +0.12 (+0.55%)

Fundamental Rating

4

Overall CFLT gets a fundamental rating of 4 out of 10. We evaluated CFLT against 282 industry peers in the Software industry. The financial health of CFLT is average, but there are quite some concerns on its profitability. CFLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CFLT had positive earnings in the past year.
In the past year CFLT had a positive cash flow from operations.
CFLT had negative earnings in each of the past 5 years.
In the past 5 years CFLT reported 4 times negative operating cash flow.
CFLT Yearly Net Income VS EBIT VS OCF VS FCFCFLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

With a Return On Assets value of -11.85%, CFLT is not doing good in the industry: 61.84% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -31.18%, CFLT is doing worse than 60.78% of the companies in the same industry.
Industry RankSector Rank
ROA -11.85%
ROE -31.18%
ROIC N/A
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
CFLT Yearly ROA, ROE, ROICCFLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

With a decent Gross Margin value of 73.92%, CFLT is doing good in the industry, outperforming 63.96% of the companies in the same industry.
CFLT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CFLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
CFLT Yearly Profit, Operating, Gross MarginsCFLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFLT has been increased compared to 1 year ago.
The number of shares outstanding for CFLT has been increased compared to 5 years ago.
Compared to 1 year ago, CFLT has an improved debt to assets ratio.
CFLT Yearly Shares OutstandingCFLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CFLT Yearly Total Debt VS Total AssetsCFLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CFLT has an Altman-Z score of 2.28. This is not the best score and indicates that CFLT is in the grey zone with still only limited risk for bankruptcy at the moment.
CFLT has a Altman-Z score of 2.28. This is comparable to the rest of the industry: CFLT outperforms 54.77% of its industry peers.
The Debt to FCF ratio of CFLT is 133.65, which is on the high side as it means it would take CFLT, 133.65 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 133.65, CFLT is in line with its industry, outperforming 44.17% of the companies in the same industry.
CFLT has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CFLT (1.07) is worse than 73.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 133.65
Altman-Z 2.28
ROIC/WACCN/A
WACC10.8%
CFLT Yearly LT Debt VS Equity VS FCFCFLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.42 indicates that CFLT has no problem at all paying its short term obligations.
CFLT has a Current ratio of 4.42. This is amongst the best in the industry. CFLT outperforms 84.10% of its industry peers.
CFLT has a Quick Ratio of 4.42. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.42, CFLT belongs to the best of the industry, outperforming 84.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 4.42
CFLT Yearly Current Assets VS Current LiabilitesCFLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

CFLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.25%, which is quite impressive.
Looking at the last year, CFLT shows a very strong growth in Revenue. The Revenue has grown by 24.10%.
The Revenue has been growing by 45.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)106.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)24.1%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%24.8%

3.2 Future

Based on estimates for the next years, CFLT will show a very strong growth in Earnings Per Share. The EPS will grow by 34.61% on average per year.
The Revenue is expected to grow by 18.92% on average over the next years. This is quite good.
EPS Next Y23.34%
EPS Next 2Y27.27%
EPS Next 3Y31.6%
EPS Next 5Y34.61%
Revenue Next Year19.67%
Revenue Next 2Y19.05%
Revenue Next 3Y19.05%
Revenue Next 5Y18.92%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CFLT Yearly Revenue VS EstimatesCFLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CFLT Yearly EPS VS EstimatesCFLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

CFLT is valuated quite expensively with a Price/Earnings ratio of 66.18.
Compared to the rest of the industry, the Price/Earnings ratio of CFLT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 25.91, CFLT is valued quite expensively.
The Price/Forward Earnings ratio is 44.95, which means the current valuation is very expensive for CFLT.
CFLT's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.77. CFLT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 66.18
Fwd PE 44.95
CFLT Price Earnings VS Forward Price EarningsCFLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CFLT.
Industry RankSector Rank
P/FCF 907.67
EV/EBITDA N/A
CFLT Per share dataCFLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CFLT does not grow enough to justify the current Price/Earnings ratio.
CFLT's earnings are expected to grow with 31.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.84
PEG (5Y)N/A
EPS Next 2Y27.27%
EPS Next 3Y31.6%

0

5. Dividend

5.1 Amount

CFLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONFLUENT INC-CLASS A

NASDAQ:CFLT (5/23/2025, 9:20:41 PM)

After market: 21.96 +0.12 (+0.55%)

21.84

-0.05 (-0.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners90.65%
Inst Owner Change16.1%
Ins Owners3.58%
Ins Owner Change16.35%
Market Cap7.42B
Analysts79
Price Target30.82 (41.12%)
Short Float %6.41%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.23%
Min EPS beat(2)16.38%
Max EPS beat(2)54.07%
EPS beat(4)4
Avg EPS beat(4)47.1%
Min EPS beat(4)16.38%
Max EPS beat(4)91.45%
EPS beat(8)8
Avg EPS beat(8)140.49%
EPS beat(12)12
Avg EPS beat(12)103.24%
EPS beat(16)16
Avg EPS beat(16)82.41%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)0.52%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.32%
Max Revenue beat(4)0.52%
Revenue beat(8)7
Avg Revenue beat(8)0.62%
Revenue beat(12)11
Avg Revenue beat(12)1.16%
Revenue beat(16)15
Avg Revenue beat(16)3.07%
PT rev (1m)-19.57%
PT rev (3m)-19.99%
EPS NQ rev (1m)7.78%
EPS NQ rev (3m)7.13%
EPS NY rev (1m)1.88%
EPS NY rev (3m)1.59%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-1.26%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 66.18
Fwd PE 44.95
P/S 7.3
P/FCF 907.67
P/OCF 227.31
P/B 7.24
P/tB 8.7
EV/EBITDA N/A
EPS(TTM)0.33
EY1.51%
EPS(NY)0.49
Fwd EY2.22%
FCF(TTM)0.02
FCFY0.11%
OCF(TTM)0.1
OCFY0.44%
SpS2.99
BVpS3.02
TBVpS2.51
PEG (NY)2.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.85%
ROE -31.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.92%
FCFM 0.8%
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 133.65
Debt/EBITDA N/A
Cap/Depr 100.4%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.42
Quick Ratio 4.42
Altman-Z 2.28
F-Score6
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)148.98%
Cap/Depr(5y)197.88%
Cap/Sales(3y)2.54%
Cap/Sales(5y)2.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y23.34%
EPS Next 2Y27.27%
EPS Next 3Y31.6%
EPS Next 5Y34.61%
Revenue 1Y (TTM)24.1%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%24.8%
Revenue Next Year19.67%
Revenue Next 2Y19.05%
Revenue Next 3Y19.05%
Revenue Next 5Y18.92%
EBIT growth 1Y3.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year373.53%
EBIT Next 3Y131.79%
EBIT Next 5YN/A
FCF growth 1Y104.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.14%
OCF growth 3YN/A
OCF growth 5YN/A